tiprankstipranks
Trending News
More News >
InDex Pharmaceuticals Holding AB (DE:1NP1)
FRANKFURT:1NP1

InDex Pharmaceuticals Holding AB (1NP1) Revenue

Compare
4 Followers

InDex Pharmaceuticals Holding AB Revenue

InDex Pharmaceuticals Holding AB had a revenue of 2.50M in the quarter ending Dec 31, 2025, with 116.67%. This bring the company's revenue in the last twelve months to 9.50M, Decreased 35.71%. In the fiscal year ending Dec 31, 2025, InDex Pharmaceuticals Holding AB had annual revenue of 8.80M with 8700.00% growth.
Revenue (ttm)
9.50M
Revenue Growth
P/S Ratio
28.65
Revenue/Employee
€1,100,000
Employees
8
Market Cap
€252.11M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
8.80M8.70M+8,700.00%
Dec 31, 2024
100.00K-97.41M-99.90%
Dec 31, 2023
97.50M+∞%
Dec 31, 2022
Dec 31, 2021
-35.00K-100.00%
Dec 31, 2020
35.00K-53.00K-60.23%
Dec 31, 2019
88.00K-40.00K-31.25%
Dec 31, 2018
128.00K15.00K+13.27%
Dec 31, 2017
113.00K